Notice of National Institutes of Health Workshop on the Enrollment and Retention of Participants in NIH-Funded Clinical Trials, 38049-38050 [2014-15681]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 128 / Thursday, July 3, 2014 / Notices
Dated: June 24, 2014.
Sarah L. Glavin,
Deputy Director, Office of Science Policy,
Analysis, and Communications, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, National
Institutes of Health.
[FR Doc. 2014–15669 Filed 7–2–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Plasticity, Neuroprotection, and
Function in Brain Injury and Cognitive
Impairment.
Date: July 24, 2014.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alessandra C Rovescalli,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Rm 5205 MSC7846,
Bethesda, MD 20892, (301) 435–1021,
rovescaa@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Plasticity, Neuroprotection, and
Function in Brain Injury and Addiction.
Date: July 25, 2014.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alessandra C Rovescalli,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Rm 5205 MSC7846,
Bethesda, MD 20892, (301) 435–1021,
rovescaa@mail.nih.gov.
VerDate Mar<15>2010
16:53 Jul 02, 2014
Jkt 232001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Neurodegenerative Disease and Injury.
Date: July 25, 2014.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Christine A Piggee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4186,
MSC 7850, Bethesda, MD 20892, 301–435–
0657, christine.piggee@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: July 28, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–451–
4467, morrowcs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Structure and Function of 3–Osulfated Heparan Sulfate.
Date: July 29–30, 2014.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kathryn M Koeller, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435–
2681, koellerk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Adverse Drug Reactions in Children.
Date: July 29, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Janet M Larkin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7840, Bethesda, MD 20892, 301–806–
2765, larkinja@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: A Resource for Biomedical Mass
Spectrometry.
Date: July 29–31, 2014.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Chase Park Plaza, 212 N.
Kingshighway, St Louis, MO 63108.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
38049
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC, Bethesda, MD 20892, belangerm@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: June 27, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15582 Filed 7–2–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine Notice of
Meetings Amended; Notice of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, Lister Hill National Center
for Biomedical Communications,
September 11, 2014, 9:00 a.m. to
September 12, 2014, 11:00 a.m.,
National Library of Medicine, Building
38, Board Room, 8600 Rockville Pike,
Bethesda, MD 20892 which was
published in the Federal Register on
June 9, 2014, 79 FR 110, Page 32968.
The meeting of the Board of Scientific
Counselors, Lister Hill National Center
for Biomedical Communications, will be
held on September 18–19, 2014 instead
of September 11–12, 2014, at 9:00 a.m.
and will end at 11:00 a.m. The meeting
is partially closed to the public.
Dated: June 27, 2014.
Michelle Trout,
Program Analyst, Office of the Federal
Advisory Committee Policy.
[FR Doc. 2014–15557 Filed 7–2–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of National Institutes of Health
Workshop on the Enrollment and
Retention of Participants in NIHFunded Clinical Trials
The National Institutes of
Health (NIH) is conducting a workshop
with interested stakeholders in order to
hear perspectives on issues related to
the enrollment and retention of research
participants in NIH-funded clinical
SUMMARY:
E:\FR\FM\03JYN1.SGM
03JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
38050
Federal Register / Vol. 79, No. 128 / Thursday, July 3, 2014 / Notices
trials. The workshop will be open to the
public.
DATES: The workshop will be held on
Friday, July 25, 2014, from 8:15 a.m. to
5:45 p.m., in the NIH Porter
Neuroscience Research Center, 35
Convent Drive, Bethesda, Maryland
20892.
FOR FURTHER INFORMATION CONTACT:
Registration and workshop information
is available at the NIH Office of Science
Policy (OSP) Web site (https://
osp.od.nih.gov). OSP’s mailing address
is 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892. Additional
questions about the workshop may be
directed to the office by calling 301–
436–9838, or by emailing OCRBP-OSP@
od.nih.gov.
SUPPLEMENTARY INFORMATION: The NIH’s
ability to improve the efficiency and
effectiveness of its clinical trials is
critical to the agency’s mission to foster
research strategies that protect and
improve human health. The goal of the
workshop is to explore strategies to
enhance enrollment, recruitment, and
retention of participants in clinical
trials.
The meeting agenda covers a range of
topics related to the enrollment and
retention of clinical trial participants,
including: current challenges in clinical
trial participant enrollment; cultural
and social considerations in clinical
trial participant enrollment and
outreach; recruitment and outreach
considerations for underrepresented and
vulnerable populations; roles for public
foundations in clinical trial participant
enrollment and retention; public private
partnerships to improve patient and
public awareness and engagement;
models to identify and support clinical
trial participants; and strategies for
tracking and monitoring clinical trial
participation and post-trial
communication. A full meeting agenda
will be available prior to the workshop
at the NIH OSP Web site (https://
od.osp.nih.gov).
The meeting will be open to the
public, with attendance limited to the
space available. Instructions for
preregistration (required) are available
on the NIH OSP Web site (https://
osp.od.nih.gov). Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
In the interest of security, the NIH has
instituted stringent procedures for
entrance onto its Bethesda campus. All
vehicles, including taxis, hotel, and
airport shuttles will be inspected before
being allowed on campus. Visitors will
VerDate Mar<15>2010
16:53 Jul 02, 2014
Jkt 232001
be asked to show one form of
identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. For more
information about the security measures
at the NIH, please visit the Web site at
https://www.nih.gov/about/
visitorsecurity.htm.
Dated: June 27, 2014.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2014–15681 Filed 7–2–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Opportunities for Collaborative
Research at the NIH Clinical Center.
Date: July 31, 2014.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7178, Bethesda, MD
20892–7924, (Telephone Conference Call).
Contact Person: William J Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7178, Bethesda, MD 20892–7924, 301–435–
0725, johnsonwj@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
Dated: June 27, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15556 Filed 7–2–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given for the meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
National Advisory Council (CSAP NAC)
on July 7, 2014.
The meeting will include the review,
discussion and evaluation of grant
applications reviewed by the Initial
Review Group, and involve an
examination of confidential financial
and business information as well as
personal information concerning the
applicants. Therefore, this meeting will
be closed to the public as determined by
the SAMHSA Administrator, in
accordance with Title 5 U.S.C.
552b(c)(4) and (6) and (c)(9)(B) and 5
U.S.C. App. 2, Section 10(d).
Substantive program information, a
summary of the meeting, and a roster of
committee members may be obtained
either by accessing the SAMHSA
Committee’s Web site after the meeting,
https://nac.samhsa.gov/, or by contacting
the council’s Designated Federal Officer.
Committee Name: Substance Abuse and
Mental Health Services, Administration
Center for Substance Abuse Prevention,
National Advisory Council.
Date/Time/Type: July 7, 2014 from 2pm to
3pm EDT: (CLOSED).
Place: Teleconference.
Contact: Matthew J. Aumen, Designated
Federal Officer, SAMHSA CSAP NAC, 1
Choke Cherry Road, Rockville, Maryland
20857, Telephone: 240–276–2419, Fax: 240–
276–2430 and Email: matthew.aumen@
samhsa.hhs.gov.
Cathy J. Friedman,
Public Health Analyst, Substance Abuse and
Mental Health, Services Administration.
[FR Doc. 2014–15568 Filed 7–2–14; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\03JYN1.SGM
03JYN1
]]>Agencies
[Federal Register Volume 79, Number 128 (Thursday, July 3, 2014)]
[Notices]
[Pages 38049-38050]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15681]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of National Institutes of Health Workshop on the
Enrollment and Retention of Participants in NIH-Funded Clinical Trials
SUMMARY: The National Institutes of Health (NIH) is conducting a
workshop with interested stakeholders in order to hear perspectives on
issues related to the enrollment and retention of research participants
in NIH-funded clinical
[[Page 38050]]
trials. The workshop will be open to the public.
DATES: The workshop will be held on Friday, July 25, 2014, from 8:15
a.m. to 5:45 p.m., in the NIH Porter Neuroscience Research Center, 35
Convent Drive, Bethesda, Maryland 20892.
FOR FURTHER INFORMATION CONTACT: Registration and workshop information
is available at the NIH Office of Science Policy (OSP) Web site (https://osp.od.nih.gov). OSP's mailing address is 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892. Additional questions about the workshop may be
directed to the office by calling 301-436-9838, or by emailing OCRBP-OSP@od.nih.gov.
SUPPLEMENTARY INFORMATION: The NIH's ability to improve the efficiency
and effectiveness of its clinical trials is critical to the agency's
mission to foster research strategies that protect and improve human
health. The goal of the workshop is to explore strategies to enhance
enrollment, recruitment, and retention of participants in clinical
trials.
The meeting agenda covers a range of topics related to the
enrollment and retention of clinical trial participants, including:
current challenges in clinical trial participant enrollment; cultural
and social considerations in clinical trial participant enrollment and
outreach; recruitment and outreach considerations for underrepresented
and vulnerable populations; roles for public foundations in clinical
trial participant enrollment and retention; public private partnerships
to improve patient and public awareness and engagement; models to
identify and support clinical trial participants; and strategies for
tracking and monitoring clinical trial participation and post-trial
communication. A full meeting agenda will be available prior to the
workshop at the NIH OSP Web site (https://od.osp.nih.gov).
The meeting will be open to the public, with attendance limited to
the space available. Instructions for preregistration (required) are
available on the NIH OSP Web site (https://osp.od.nih.gov). Individuals
who plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
In the interest of security, the NIH has instituted stringent
procedures for entrance onto its Bethesda campus. All vehicles,
including taxis, hotel, and airport shuttles will be inspected before
being allowed on campus. Visitors will be asked to show one form of
identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit. For more
information about the security measures at the NIH, please visit the
Web site at https://www.nih.gov/about/visitorsecurity.htm.
Dated: June 27, 2014.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2014-15681 Filed 7-2-14; 8:45 am]
BILLING CODE 4140-01-P
